This commentary provides a definition of textual case-based reasoning (TCBR) and surveys research contributions according to four research questions. We also describe how TCBR can be distinguished from text mining and information retrieval. We conclude with potential directions for TCBR research.
This commentary describes two core knowledge management approaches that applied case-based reasoning as a methodological foundation for organizational systems managing experience. These research projects illustrate the presence of knowledge management in case-based reasoning by focusing on the dualism between case-based reasoning and organizational approaches targeting knowledge management goals.
Researchers focusing on how artificial intelligence (AI) methods explain their decisions often discuss controversies and limitations. Some even assert that most publications offer little to no valuable contributions. In this article, we substantiate the claim that explainable AI (XAI) is in trouble by describing and illustrating four problems: the disagreements on the scope of XAI, the lack of definitional cohesion, precision, and adoption, the issues with motivations for XAI research, and limited and inconsistent evaluations. As we delve into their potential underlying sources, our analysis finds these problems seem to originate from AI researchers succumbing to the pitfalls of interdisciplinarity or from insufficient scientific rigor. Analyzing these potential factors, we discuss the literature at times coming across unexplored research questions. Hoping to alleviate existing problems, we make recommendations on precautions against the challenges of interdisciplinarity and propose directions in support of scientific rigor.
The growing availability of biomedical data offers vast potential to improve human health, but the complexity and lack of integration of these datasets often limit their utility. To address this, the Biomedical Data Translator Consortium has developed an open‐source knowledge graph–based system—Translator—designed to integrate, harmonize, and make inferences over diverse biomedical data sources. We announce here Translator's initial public release and provide an overview of its architecture, standards, user interface, and core features. Translator employs a scalable, federated, knowledge graph framework for the integration of clinical, genomic, pharmacological, and other biomedical knowledge sources, enabling query retrieval, inference, and hypothesis generation. Translator's user interface is designed to support the exploration of knowledge relationships and the generation of insights, without requiring deep technical expertise and gradually revealing more detailed evidence, provenance, and confidence information, as needed by a given user. To demonstrate Translator's application and impact, we highlight features of the user interface in the context of three real‐world use cases: suggesting potential therapeutics for patients with rare disease; explaining the mechanism of action of a pipeline drug; and screening and validating drug candidates in a model organism. We discuss strengths and limitations of reasoning within a largely federated system and the need for rich concept modeling and deep provenance tracking. Finally, we outline future directions for enhancing Translator's functionality and expanding its data sources. Translator represents a significant step forward in making complex biomedical knowledge more accessible and actionable, aiming to accelerate translational research and improve patient care.